Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06995768 · ClinicalTrials.gov registry record
Normative Data for Sweating Rate, Sweat Sodium Concentration and Sweat Sodium Loss in Female Athlete
A clinical trial of Sweat Rate, sponsored by PepsiCo Global R&D.
- Recruiting
- Registry status
- 500
- Enrollment target
- 1
- Study location
NCT06995768: Recruiting study of Sweat Rate, sponsored by PepsiCo Global R&D.
NCT06995768 is a study of Sweat Rate that is actively recruiting participants, run by PepsiCo Global R&D. The registered enrollment target is 500 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06995768, a study of Sweat Rate, is actively recruiting participants, sponsored by PepsiCo Global R&D.
- RECRUITING
- Registry status
- 500 participants
- Enrollment target
- 1
- Study location
Study Summary
The main objectives are to determine sweat sodium concentration \[Na+\], whole body sweat rate (WBSR) and rate of sweat sodium loss (RSSL) in female athletes aged 13 and above during their normal planned training session across various sports (basketball, soccer, volleyball, cheer, flag football and softball).
Primary Outcome
Absorbent patch technique (3M TegadermTM + Pad; 3M, St. Paul, MN; pad size 10 cm2 with an absorbent capacity of \~1.3 g) to left and right dorsal arm. An additional patch on the right scapula may be added depending on the accessibility to the sites on the body and the nature of the sport. Analyzed using a HORIBA (LAQUAtwin Na-11)
Conditions Studied
Interventions
- OTHER Sweat patch
Study Locations (1)
Illinois
- Gatorade Sports Science Institute - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2025-04-22 |
| Est. Completion | 2026-06-30 |
What NCT06995768 shows while recruiting
NCT06995768 is an observational study that tracks outcomes without assigning an intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Sweat Rate appearing as the primary indexed condition, and to 1 intervention - of which Sweat patch is the first listed.
NCT06995768 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT06995768 about?
NCT06995768 is a clinical study titled "Normative Data for Sweating Rate, Sweat Sodium Concentration and Sweat Sodium Loss in Female Athlete". The main objectives are to determine sweat sodium concentration \[Na+\], whole body sweat rate (WBSR) and rate of sweat sodium loss (RSSL) in female athletes aged 13 and above during their normal planned training session across various sports (basketball, soccer, volleyball, cheer, flag football and...
What is the current status of trial NCT06995768?
This trial is currently recruiting. The enrollment target is 500 participants. The study started on 2025-04-22. Estimated completion is 2026-06-30.
What conditions does trial NCT06995768 study?
This clinical trial studies the following conditions: Sweat Rate.
What interventions are being tested in trial NCT06995768?
The interventions under investigation include: Sweat patch (OTHER).
Who is sponsoring clinical trial NCT06995768?
This trial is sponsored by PepsiCo Global R&D, which has 47 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06995768 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI